Substance Use Disorder

Synonyms
SUD
Addiction
drug use
THC
Stimulant
Addict
methamphetamine
cocaine
marijuana

2021 National Survey of Drug Use and Health (NSDUH) Releases

The National Survey on Drug Use and Health (NSDUH) is conducted annual and provides nationally representative data on the use of substances (tobacco, alcohol, and drugs), substance use disorders, those who received substance use treatment, and mental health issues and services. This survey is conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Posted Date
01/31/23

SAMHSA Announces Funding Opportunities for Grants Addressing Substance Misuse, Substance Use Disorder Treatment on Multiple Fronts

Five notices of funding opportunities (NOFOs) for grant programs was announced by the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA). The $73.4 million in total is aimed at preventing substance misuse and treating OUD and is aligned with the Biden-Harris administration's current efforts. 
Posted Date
01/17/23

Increasing Access to Buprenorphine Services

The Substance Abuse and Mental Health Services Administration released a notice of proposed rulemaking that would allow certified opioid treatment programs to begin prescribing the drug via audio-only or video-enabled telehealth. See additional information under Policy Updates below. The proposed changes come on top of recent findings by HHS of the positive impact of its revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that removed two longstanding requirements for obtaining a waiver to treat up to 30 patients with buprenorphine: 1) the requirement for specific training, and 2) the need for otherwise eligible clinicians to certify their ability to provide or refer patients for counseling and other services. Rural primary care providers have obtained the DEA waiver at a lower rate than urban clinicians; decreased burden and greater flexibility in the guidelines, along with broader use of telehealth could help close that gap.
Posted Date
12/21/22

HHS Proposes New Protections to Increase Care Coordination and Confidentiality for Patients With Substance Use Challenges

This week, the U.S. Health and Human Services Department, through the Office for Civil Rights (OCR) and the Substance Abuse and Mental Health Services Administration (SAMHSA), announced proposed changes to the Confidentiality of Substance Use Disorder (SUD) Patient Records under 42 CFR part 2 (“Part 2”), which protects patient privacy and records concerning treatment related to substance use challenges from unauthorized disclosures.
Posted Date
12/06/22

HHS Studies SUD Treatment for People of Color

To more effectively address known barriers to treatment for substance use disorder (SUD), policy researchers looked at feedback from 27 community-based programs serving predominantly people of color across the U.S. Beyond poverty and racism, providers describe challenges retaining staff with appropriate language and cultural skills as well as a complex patchwork of social skills. 
Posted Date
12/06/22

HHS Proposes Major Changes to SUD Treatment Record-Sharing

The Department of Health and Human Services today issued a notice of public rulemaking to improve the exchange of patient records used in the treatment of substance use disorder. HHS proposes provisions to implement section 3221 of the Coronavirus Aid, Relief, and Economic Security Act to ensure providers have more complete and timely information when treating patients with SUD, including updating patient consent requirements and aligning disclosure requirements with those under HIPAA regulations. AHA is among a host of organizations who have pushed for such changes, including one which would enable providers to get a patient’s consent just once to share substance use records for treatment and health care operations. HHS will accept comments for the next 60 days.
Posted Date
11/30/22

RCORP Disparities Impact Statement Webinar Materials

This webinar provided RCORP grantees with the tools to complete a disparities impact statement, to support efforts to address populations in rural communities that have historically suffered from poorer health outcomes and health inequities as a part of the prevention, treatment, and recovery of SUD/OUD.
Posted Date
11/23/22

Disparities Impact Statement (DIS) Guidance and Template

The Disparities Impact Statement (DIS) template is a deliverable for this project that you will be required to complete. There was a webinar discussing the DIS for all relevant cohorts on November 15, 2022. This webinar provided RCORP grantees with the tools to complete a disparities impact statement, to support efforts to address populations in rural communities that have historically suffered from poorer health outcomes and health inequities as a part of the prevention, treatment, and recovery of SUD/OUD. We strongly encourage you to review these documents or listen to the recording when it is posted to the RCORP- TA portal at a later date. Please be in contact with your Technical Expert Lead (TEL) with any questions. 
Posted Date
11/16/22

HRSA Payment Program for RHC Buprenorphine-Trained Providers

In June 2021, HRSA launched an effort to improve access to substance use disorder treatment by paying for providers who are waivered to prescribe buprenorphine, a medication used to treat opioid use disorder.  Rural Health Clinics (RHCs) still have the opportunity to apply for a $3,000 payment on behalf of each provider who trained to obtain the waiver necessary to prescribe buprenorphine after January 1, 2019.
Posted Date
11/14/22